Pathology of catheter-related complications: what we need to know and what should be discovered

被引:16
作者
Wang, Lihua [1 ,2 ]
Jia, Lan [1 ,2 ]
Jiang, Aili [1 ,2 ]
机构
[1] Tianjin Med Univ, Hosp 2, Dept Kidney Dis, Tianjin, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Blood Purificat Ctr, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
Tunneled cuffed catheter; hemodialysis; pathology; complication; thrombosis; infection; central vein stenosis; CENTRAL VENOUS CATHETERS; CUFFED HEMODIALYSIS CATHETERS; VASCULAR ACCESS; JUGULAR-VEIN; DIALYSIS; THROMBOSIS; BLOOD; DYSFUNCTION; PREVENTION; MODEL;
D O I
10.1177/03000605221127890
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite the considerable efforts made to increase the prevalence of autogenous fistula in patients on hemodialysis, tunneled cuffed catheters are still an important access modality and used in a high percentage of the hemodialysis population. However, because of the conundrum posed by tunneled cuffed catheters, patients can develop a multitude of complications, including thrombosis, infections, formation of a fibrin sheath, and central vein stenosis, resulting in increased morbidity and mortality as well as placing a heavy burden on the healthcare system. However, with an increasing number of studies now focusing on how to manage these catheter-related complications, there has been less translational research on the pathology of these complications. This review of the most recent literature provides an update on the pathological aspects of catheter-related complications, highlighting what we need to know and what is yet to be discovered. The future research strategies and innovations needed to prevent these complications are also addressed.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?
    Reyes, Cesar
    Patarroyo, Manuel A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 945
  • [32] Does prophylactic anticoagulation reduce the risk of femoral tunneled dialysis catheter-related complications?
    Herrington, William G.
    Nye, Helen J.
    Haynes, Richard J.
    Winearls, Christopher G.
    Vaux, Emma C.
    JOURNAL OF VASCULAR ACCESS, 2013, 14 (02) : 135 - 142
  • [34] Emerging Zika virus infection:What should we know?
    Viroj Wiwanitkit
    Asian Pacific Journal of Tropical Biomedicine, 2016, (07) : 551 - 553
  • [35] Factor XI inhibitors: what should clinicians know
    Pandey, Arjun
    Verma, Raj
    Eikelboom, John
    Verma, Subodh
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (02) : 88 - 93
  • [36] Central Venous Catheter-Related Complications
    Yesil, Sule
    Tanyildiz, Hikmet Gulsah
    Ardicli, Burak
    Tekgunduz, Sibel Akpinar
    Candir, Mehmet Onur
    Toprak, Sule
    Bozkurt, Ceyhun
    Sahin, Gurses
    GAZI MEDICAL JOURNAL, 2014, 25 (04): : 135 - 137
  • [37] A Summary of Coronavirus Disease 2019: What We Should Know?
    Ysrafil, Ysrafil
    Astuti, Indwiani
    Mus, Rosdiana
    Gama, Noviyanty Indjar
    Rahmaisyah, Dwi
    Nur'amalia, Riskah
    PHARMACEUTICAL SCIENCES, 2020, 26 : S24 - S35
  • [38] Coronaviruses: What Should We Know About the Characteristics of Viruses?
    Ji, Wei
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 23 - 39
  • [39] A prospective study of catheter-related complications in HPN patients
    Gillanders, Lyn
    Angstmann, Katherina
    Ball, Patrick
    O'Callaghan, Margie
    Thomson, Andrew
    Wong, Theodoric
    Thomas, Mark
    CLINICAL NUTRITION, 2012, 31 (01) : 30 - 34
  • [40] Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center
    Pektas, Ayhan
    Kara, Ates
    Gurgey, Aytemiz
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 144 - 151